ATXS
Price
$6.51
Change
-$0.16 (-2.40%)
Updated
Aug 27 closing price
Capitalization
367.39M
76 days until earnings call
GLSI
Price
$11.68
Change
-$0.25 (-2.10%)
Updated
Aug 27, 04:59 PM (EDT)
Capitalization
162.61M
75 days until earnings call
Interact to see
Advertisement

ATXS vs GLSI

Header iconATXS vs GLSI Comparison
Open Charts ATXS vs GLSIBanner chart's image
Astria Therapeutics
Price$6.51
Change-$0.16 (-2.40%)
Volume$154.15K
Capitalization367.39M
Greenwich LifeSciences
Price$11.68
Change-$0.25 (-2.10%)
Volume$200
Capitalization162.61M
ATXS vs GLSI Comparison Chart in %
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. GLSI commentary
Aug 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a StrongBuy and GLSI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 28, 2025
Stock price -- (ATXS: $6.51 vs. GLSI: $11.67)
Brand notoriety: ATXS and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 56% vs. GLSI: 25%
Market capitalization -- ATXS: $367.39M vs. GLSI: $162.61M
ATXS [@Biotechnology] is valued at $367.39M. GLSI’s [@Biotechnology] market capitalization is $162.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $99.27B to $0. The average market capitalization across the [@Biotechnology] industry is $1.85B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, ATXS is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while GLSI’s TA Score has 3 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 2 bearish.
  • GLSI’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, ATXS is a better buy in the short-term than GLSI.

Price Growth

ATXS (@Biotechnology) experienced а +3.17% price change this week, while GLSI (@Biotechnology) price change was -2.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.04%. For the same industry, the average monthly price growth was +19.75%, and the average quarterly price growth was +30.54%.

Reported Earning Dates

ATXS is expected to report earnings on Nov 12, 2025.

GLSI is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+4.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($367M) has a higher market cap than GLSI($163M). GLSI YTD gains are higher at: 6.233 vs. ATXS (-27.181). GLSI has higher annual earnings (EBITDA): -18.14M vs. ATXS (-131.42M). ATXS has more cash in the bank: 259M vs. GLSI (3.13M). ATXS (0) and GLSI (0) have equivalent revenues.
ATXSGLSIATXS / GLSI
Capitalization367M163M225%
EBITDA-131.42M-18.14M725%
Gain YTD-27.1816.233-436%
P/E RatioN/AN/A-
Revenue00-
Total Cash259M3.13M8,288%
Total Debt4.77MN/A-
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
50
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSGLSI
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
76%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LLYVB100.00N/A
N/A
Liberty Media Corporation
NNMTF0.95N/A
N/A
Nine Entertainment Co. Holdings Ltd
CTNR5.00N/A
N/A
Central Natural Resources, Inc.
PHYTF11.81N/A
N/A
Pyrophyte Acquisition Corp.
SMAWF270.36-5.09
-1.85%
Siemens AG

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
-2.40%
CRNX - ATXS
52%
Loosely correlated
-1.71%
XENE - ATXS
51%
Loosely correlated
+0.57%
NRIX - ATXS
51%
Loosely correlated
+0.21%
DNLI - ATXS
50%
Loosely correlated
+0.32%
COGT - ATXS
49%
Loosely correlated
+1.14%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+0.34%
ABOS - GLSI
44%
Loosely correlated
-3.31%
IMNM - GLSI
43%
Loosely correlated
+2.42%
BEAM - GLSI
42%
Loosely correlated
+1.22%
DNLI - GLSI
41%
Loosely correlated
-0.13%
ATXS - GLSI
40%
Loosely correlated
+3.89%
More